Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04992013
Title Niraparib in Tumors Metastatic to the CNS
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Massachusetts General Hospital
Indications

triple-receptor negative breast cancer

ovarian cancer

Advanced Solid Tumor

Therapies

Niraparib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST